SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-040170
Filing Date
2024-09-05
Accepted
2024-09-05 09:23:54
Documents
1
Group Members
CHRISTOPHER L. GUSTROBERT R. BELLICKWOLVERINE HOLDINGS, L.P.WOLVERINE TRADING PARTNERS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20035496_sc13ga.htm SC 13G/A 160142
  Complete submission text file 0001140361-24-040170.txt   161938
Mailing Address 175 WEST JACKSON SUITE 340 CHICAGO IL 60604
Business Address 175 W. JACKSON SUITE 340 CHICAGO IL 60064 3128844400
WOLVERINE ASSET MANAGEMENT LLC (Filed by) CIK: 0001279891 (see all company filings)

IRS No.: 020611276
Type: SC 13G/A

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Subject) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93794 | Film No.: 241280137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)